Clinical Trials
CLEAR SYNERGY OASIS 9
Status:Ongoing
A 2×2 factorial randomized controlled trial of CoLchicine and spironolactonE in patients with myocARdial infarction/SYNERGY Stent Registry – Organization to Assess Strategies for Ischemic Syndromes 9
Email Study Contact:
[email protected]HD PCI
Status:Ongoing
HD PCI is a multicenter, international, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI) for non-ST elevation acute coronary syndrome (NSTEACS) or stable angina.
Email Study Contact:
[email protected]COMPLETE-2
Status:Ongoing
A prospective, multi-centre randomized trial of physiology-guided versus angiography-guided non-culprit lesion complete revascularization strategies in patients with acute myocardial infarction and multi-vessel coronary artery disease who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI).
Email Study Contact:
[email protected]LAAOS-4
Status:Ongoing
A multi-centre, prospective, open-label, randomized controlled trial with blinded assessment of endpoints (PROBE) to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Email Study Contact:
[email protected]STEMI DTU
Status:Ongoing
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI DTU Trial
Email Study Contact:
[email protected]ARTEMIS
Status:Ongoing
Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Email Study Contact:
[email protected]ABBREVIATE
Status:Ongoing
De-Adoption βeta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a pragmaTic randomizEd trial with blinded endpoints (ABBREVIATE) is a multi-centre vanguard project taking place within Alberta.
SONO-STEMILYSIS
Status:Ongoing
Open label, single-centre, randomized investigation of sonothrombolysis in 60 adult patients presenting with STEMI within 6 hours of the onset of clinical symptoms and receiving perfusion therapy with fibrinolysis as part of a pharmacoinvasive strategy.
Email Study Contact:
[email protected]STICH3C
Status:Ongoing
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Email Study Contact:
[email protected]NEPTUNE
Status:Ongoing
ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions (NEPTUNE)
PRACTICAL HERO
Status:Ongoing
A Randomized Trial of Heparin vs Placebo for Cardiac Catheterization Via the Trans-radial Approach
Email Study Contact:
[email protected]NACMI ECG
Status:Ongoing
N orth A merican C OVID-19 ST-Segment-Elevation M yocardial I nfarction (NACMI) registry: Rationale, design, and implications
Canadian INOCA Physiology Registry
Status:Ongoing
Canadian INOCA ( Ischemia with no obstructive arteries) Physiology Registry